We further show the capacity of Evo, an alkaloid derived from Evodia rutaecarpa68, as an HSP70 inhibitor to suppress CSC populations of lung, breast, and colon cancer cells at submicromolar concentrations and bulk non-CSC populations at micromolar concentrations. The gene discussed is HSPA4; the disease is malignant colon neoplasm.